Notifications
2016_01_28 Data Snapshot
Barcode | UUID | Date | Type | Category | Notes |
---|---|---|---|---|---|
TCGA-CS-6665 | c16d9f69-26f9-4ec7-b2d5-ff9f7dacfe0f | 10/31/2012 | LGG | Prior malignancy | Prior malignancy breast cancer treated with radiation |
TCGA-CS-6665 | c16d9f69-26f9-4ec7-b2d5-ff9f7dacfe0f | 11/10/2012 | LGG | History of acceptable prior treatment related to a prior/other malignancy | Prior malignancy breast cancer treated with radiation |
TCGA-CS-6670 | 60b30a95-3e4c-413a-9de6-16a5bca163c4 | 09/26/2014 | LGG | Case submitted is found to be a recurrence after submission | Patient diagnosed with oligodendroma 5 years prior to procurement of the TCGA specimen and had prior treatment (Temodar). The TSS did confirm the TCGA tumor was a recurrence. |
TCGA-DB-5270 | b7cd3b44-ef6a-4207-a44f-14f5b3b56ed4 | 06/16/2014 | LGG | Case submitted is found to be a recurrence after submission | patient had a prior lower grade glioma |
TCGA-DB-5270 | b7cd3b44-ef6a-4207-a44f-14f5b3b56ed4 | 10/10/2011 | LGG | Item does not meet study protocol | [intgen.org]: Sample sent to TCGA was not the primary tumor. The initial surgery was a biopsy only with a diagnosis of a grade II oligodendroglioma where tumor was not completely removed. The patient did not receive any pharmaceutical or radiation therapy. Sample submitted was a progression of the tumor to a grade III oligodendroglioma |
TCGA-DH-5141 | 2cf49bac-dea1-45ff-9e1d-09f5a2ac5215 | 06/16/2014 | LGG | Case submitted is found to be a recurrence after submission | patient had a prior lower grade glioma |
TCGA-DU-7011 | cb598780-9e42-4167-b487-eec90ad4f36f | 11/10/2012 | LGG | Case submitted is found to be a recurrence after submission | Sample sent to TCGA was not the primary tumor, it was a recurrence. |
TCGA-DU-7300 | a144e4e4-2877-4340-a2bf-524adbde8bc8 | 10/31/2012 | LGG | Prior malignancy | Prior malignancy melanoma. No systemic chemotherapy or radiation. |
TCGA-DU-7300-10A-01W | (none) | 03/10/2012 | LGG | WGA Failure | Sample 7300-10A is considered unacceptable because it had a higher proportion of homozygous calls then expected despite it being the 2nd WGA amplification during SNP analysis. The native DNA of the tumor and normal have been shipped and uploaded to all of the centers in Batch 189 and will be included in the canonical study. The WGA analyte is used as a control for the canonical study, but since the WGA analyte has disqualified through SNP analysis, the WGA analytes for case 7300 will not be shipped or uploaded. |
TCGA-FG-5962 | e09f93e1-1649-48fa-9e2e-d13ac6d50b97 | 10/31/2012 | LGG | Normal tissue origin incorrect | Samples were created as tssDNA from Normal Tissue. Actually are tssDNA extracted from Blood. Should have been 10A instead of 11A. |
TCGA-FG-5963-11A | (none) | 05/21/2011 | LGG | Normal tissue origin incorrect | [intgen.org]: Normal tissue origin incorrect Case classified as extracted DNA from Normal Tissue. Should be DNA extracted from Blood. |
TCGA-FG-5964-11A | (none) | 05/21/2011 | LGG | Normal tissue origin incorrect | [intgen.org]: Normal tissue origin incorrect Case classified as extracted DNA from Normal Tissue. Should be DNA extracted from Blood. |
TCGA-FG-8187 | 0df37550-9421-4571-9844-51b457d7cb2b | 02/01/2013 | LGG | Prior malignancy | Patient had prior testicular germ cell tumor. No radiation or systemic chemotherapy. |
TCGA-FG-8187 | 0df37550-9421-4571-9844-51b457d7cb2b | 10/31/2012 | LGG | Prior malignancy | Prior malignancy testicular cancer. No systemic chemotherapy or radiation. |
TCGA-HT-7604 | 019c5de9-74fd-48b7-95a3-227532e16c5a | 12/11/2014 | LGG | Case submitted is found to be a recurrence after submission | patient had prior LGG malignancy (and complete resection) 5 years prior to TCGA malignancy. No treatment was given prior to procurement of TCGA specimen. |
TCGA-HT-A619 | c13bac88-c85b-4ee3-a51c-fd503cd7e726 | 12/19/2014 | LGG | History of unacceptable prior treatment related to a prior/other malignancy | Patient had a prior LGG diagnosis, surgery and radiation to the head. TCGA tumor was resected 10 years later. |
TCGA-HW-7490 | c3c41fd2-f0d7-4f46-9e18-cce4626538c2 | 01/24/2012 | LGG | Prior malignancy | [intgen.org]: Prior malignancy of thyroid. No systemic treatment or radiation given. |
TCGA-IK-8125 | a0b7c7c8-a6f2-41ba-9e61-9b7f8fbbbe1f | 10/31/2012 | LGG | Prior malignancy | Prior malignancy basal cell carcinoma of the nose. No systemic chemotherapy or radiation. |
TCGA-P5-A5EY | 1f33aebc-edc1-42c5-baa9-e4b0a06fcb26 | 06/16/2014 | LGG | Neoadjuvant therapy | systemic treatment |
TCGA-R8-A6ML | 5119aceb-ad95-4904-b6c0-a0a4b42c17d0 | 07/01/2015 | LGG | Neoadjuvant therapy | During enrollment, the TSS discovered the patient had temozolomide chemotherapy prior to the TCGA cancer procurement. |
TCGA-R8-A73M | dc7ec60b-5ea5-48a4-8908-55caf9214272 | 06/16/2014 | LGG | History of unacceptable prior treatment related to a prior/other malignancy | unknown treatment history |